Radiant Genomics is developing a synthetic biology platform that provides industrially scalable access to the chemistry encoded by natural organisms. Our target end-markets include but are not limited to, agriculture, pharmaceuticals, and speciality chemicals. Please contact us for more information regarding investment and/or career opportunities.
Location: United States, California, Emeryville
Employees: 11-50
Founded date: 2012
Mentions in press and media 1
| Date | Title | Description |
| 13.12.2018 | Zymergen Raises $400m Series C in Largest Ever Upstream AgriFood Tech Deal in US | *Editor’s Note: This story has been updated to include comment from Matt Ocko, co-managing director and co-founder of Data Collective VC. Zymergen, a synthetic biology startup engineering microbes for a range of tasks, has closed a $400 mil... |